Home›Companies›Juvena Therapeutics

Juvena Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 25, 2025·Suggest an edit

About Juvena Therapeutics

Juvena Therapeutics is a private company based in Redwood City, California. It has reported $34,808,873 raised in two offerings on Form D since February 2018. Its chief executive is Hanadie Yousef.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 27, 2025Jul 25, 2025$30,493,884of $41.0M target12$2.5MEquityRule 506(b)Form D ↗
Feb 7, 2018Feb 26, 2018$4,314,989of $4.3M target23$187KEquityRule 506(b)Form D ↗
Total, two offerings$34,808,873

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Juvena Therapeutics's Form D filed Jul 25, 2025.

SJ
Steven James
Director
BH
Ben Hemani
Director
HY
Hanadie Yousef
Chief Executive Officer and director

Sources

  1. SECJuvena Therapeutics, Inc. filing history